Elligo Clinical Research Center - Austin

Austin, Texas 78704

0 studies enrolling now · 1 studies all time

What they study most

Obesity and Overweight

Studies at this site

• Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants — Completed